Marcus E Peter Selected Research

Fas Ligand Protein (Fas Ligand)

10/2018	CD95/Fas ligand mRNA is toxic to cells.
1/2018	Non-apoptotic Fas (CD95) Signaling on T Cells Regulates the Resolution of Th2-Mediated Inflammation.
1/2018	Identification of DISE-inducing shRNAs by monitoring cellular responses.
10/2017	Induction of DISE in ovarian cancer cells in vivo.
1/2017	CD95/Fas Increases Stemness in Cancer Cells by Inducing a STAT1-Dependent Type I Interferon Response.
11/2014	CD95 and CD95L promote and protect cancer stem cells.
4/2014	Death induced by CD95 or CD95 ligand elimination.
1/2014	DICE: A novel tumor surveillance mechanism-a new therapy for cancer?
6/2010	Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond.
5/2010	CD95 promotes tumour growth.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marcus E Peter Research Topics

Disease

43	Neoplasms (Cancer) 01/2022 - 09/2003
10	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 07/2007
5	Neoplasm Metastasis (Metastasis) 11/2021 - 04/2008
3	Glioblastoma (Glioblastoma Multiforme) 01/2017 - 03/2013
2	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2014
2	Glioma (Gliomas) 01/2017 - 04/2015
2	Carcinogenesis 06/2011 - 05/2010
1	Kaposi Sarcoma (Kaposi's Sarcoma) 02/2020
1	Eosinophilia 01/2018
1	Pneumonia (Pneumonitis) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2017
1	Hypoxia (Hypoxemia) 04/2015
1	Brain Neoplasms (Brain Tumor) 04/2015
1	Carcinoma (Carcinomatosis) 03/2013
1	Adenocarcinoma 06/2011
1	Urinary Bladder Neoplasms (Bladder Cancer) 03/2011
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 06/2010
1	Colonic Neoplasms (Colon Cancer) 06/2010
1	Colitis 06/2010
1	Ascites 04/2008
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2008
1	Autoimmune Lymphoproliferative Syndrome 11/2004
1	Autoimmune Diseases (Autoimmune Disease) 11/2004
1	Blister (Bulla) 09/2002

Drug/Important Bio-Agent (IBA)

17	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2007
13	Fas Ligand Protein (Fas Ligand)IBA 10/2018 - 08/2004
5	Small Interfering RNA (siRNA)IBA 01/2022 - 11/2004
5	Death Domain ReceptorsIBA 01/2018 - 11/2004
5	LigandsIBA 01/2018 - 05/2005
5	Pharmaceutical PreparationsIBA 12/2014 - 09/2003
4	Proteins (Proteins, Gene)FDA Link 04/2012 - 11/2003
4	Cadherins (E-Cadherin)IBA 03/2011 - 07/2007
3	3' Untranslated Regions (3' UTR)IBA 01/2022 - 10/2017
2	Transcription Factors (Transcription Factor)IBA 01/2021 - 03/2011
2	PlatinumIBA 01/2021 - 01/2021
2	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 04/2012
2	Interferon Type IIBA 01/2020 - 01/2017
2	Messenger RNA (mRNA)IBA 10/2018 - 04/2012
2	Phosphotransferases (Kinase)IBA 01/2017 - 11/2004
2	DNA (Deoxyribonucleic Acid)IBA 01/2012 - 03/2011
2	VimentinIBA 04/2008 - 07/2007
2	NF-kappa B (NF-kB)IBA 11/2004 - 10/2004
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2021
1	CaspasesIBA 01/2020
1	Mutant Proteins (Protein, Mutant)IBA 10/2018
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2017
1	GoldIBA 04/2015
1	Nucleic AcidsIBA 04/2015
1	Monoclonal AntibodiesIBA 12/2014
1	AntigensIBA 12/2014
1	RNA-Binding Proteins (RNA-Binding Protein)IBA 06/2014
1	Protein Isoforms (Isoforms)IBA 06/2014
1	Heterogeneous-Nuclear Ribonucleoprotein Group MIBA 06/2014
1	Caspase 8 (Caspase-8)IBA 04/2014
1	Taxoids (Taxanes)IBA 04/2012
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2012
1	Differentiation AntigensIBA 01/2012
1	LipidsIBA 10/2011
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2011
1	Interleukin-8 (Interleukin 8)IBA 10/2011
1	Fatty Acid-Binding ProteinsIBA 10/2011
1	AdipokinesIBA 10/2011
1	GSK 1363089IBA 06/2011
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 06/2011
1	Indicators and Reagents (Reagents)IBA 06/2011
1	ChromatinIBA 03/2011
1	AzoxymethaneIBA 06/2010
1	Dextran SulfateIBA 06/2010
1	Biomarkers (Surrogate Marker)IBA 04/2008
1	IntegrinsIBA 04/2008
1	Immunoglobulin G (IgG)IBA 04/2008
1	adhesion receptorIBA 04/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 08/2004
1	Antineoplastic Agents (Antineoplastics)IBA 09/2003
1	Caspase 3 (Caspase-3)IBA 09/2002
1	K-18 conjugate (K18)IBA 09/2002

Therapy/Procedure

17	Therapeutics 01/2022 - 09/2003
3	Drug Therapy (Chemotherapy) 01/2021 - 08/2004
1	Aftercare (After-Treatment) 01/2021
1	Immunotherapy 12/2014
1	Traction 01/2014